Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis
All of the women were on an adjuvant aromatase inhibitor or a selective estrogen receptor modulator, and had been using a vaginal estrogen for an average of 20 months to treat severe atrophic vaginitis
All of the women were on an adjuvant aromatase inhibitor or selective estrogen receptor modulator and had been using a vaginal estrogen for an average of 20 months to treat severe atrophic vaginitis
For women who do not have a medical history that would contraindicate estrogen use, low-dose topical estrogen cream for a short-term course may be helpful in alleviating atrophic vaginitis
Basically, the tissues in and around the vagina become thinner and prone to infection and inflammation - a condition known as atrophic vaginitis
The 11 randomized cases included diagnoses of endometrial adenocarcinoma (SP); low-grade squamous intraepithelial lesion (TP and SP); high-grade squamous intraepithelial lesion (TP and SP); atypical squamous cells, cannot rule out high-grade lesion (SP); atrophic vaginitis
(SP); Trichomonas vaginitis (TP); herpes (TP); adenocarcinoma in situ (SP); and negative for intraepithelial lesion and malignancy with bacterial shift (SP).
The Food and Drug Administration has approved a 10-mcg dose of estradiol in vaginal tablet form to treat atrophic vaginitis
associated with menopause.
Goldstein cautioned clinicians not to assume that the cause of dyspareunia in menopausal women is always atrophic vaginitis
Few would dispute the inappropriateness of subjecting a bedridden end-stage Alzheimer's patient to a pelvic examination to rule out atrophic vaginitis
The most important thing to realize is that atrophic vaginitis
is the most common symptom of natural menopause and extremely common in breast cancer survivors.
The interpretation of atrophic vaginitis
from Papanicolaou (Pap) tests is seemingly subjective, despite descriptive terminology criteria published by the Bethesda System for Reporting Cervical Cytology, (1) as evidenced by the historically poor performance on these slides in the College of American Pathologists (CAP) Interlaboratory Comparison Program in Gynecologic Cytopathology (PAP Education).
Leveraging Upsher-Smith's experienced sales force, we are able to maintain our commitment to patient care and the medical community by making sure that physicians are aware of Vagifem 10 mcg for treating menopausal women with symptoms of atrophic vaginitis
Given that atrophic vaginitis
is a progressive condition, potentially leading not only to more discomfort, but also urinary incontinence, uterine prolapse, vaginal and urinary tract infections, and severe dyspareunia, vaginal estrogen is a key strategy in prevention of these outcomes.
Contact dermatitis was the most common diagnosis, occurring in 17% of patients, followed by recurrent vulvovaginal candidiasis (16% of patients), atrophic vaginitis
(12% of patients), vulvar vestibulitis syndrome (10% of patients), physiologic leukorrhea (7% of patients), desquamative inflammatory vaginitis (DIV) (6% of patients), and recurrent bacterial vaginosis (5% of patients).
in line with medical recommendations for women to use the lowest effective estrogen dose to treat the symptoms of atrophic vaginitis
due to menopause.